Time to discontinuation among the three second-generation antidepressants in a naturalistic outpatient setting of depression

Psychiatry Clin Neurosci. 2011 Dec;65(7):630-7. doi: 10.1111/j.1440-1819.2011.02275.x.

Abstract

Aim: This study compared the discontinuation time among the three second-generation antidepressants (paroxetine, venlafaxine, and mirtazapine) in a naturalistic setting for outpatient treatment of depression.

Methods: This study used data from retrospectively reviewed medical records of patients admitted to an outpatient psychiatric clinic between January 2003 and December 2005. Patient groups (paroxetine-, venlafaxine-, and mirtazapine-treated) were compared with each other with regard to their discontinuation times for a 6-month period after treatment initiation. The data were analyzed, using a Kaplan-Meier survival analysis, and a Cox proportional hazards regression model.

Results: There were no significant differences in discontinuation times among the three second-generation antidepressants during the 6-month period after initiation of drug therapy.

Conclusions: In a naturalistic setting for the care of depression, it seems that there are no differences in discontinuation times among these three second-generation antidepressants.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antidepressive Agents, Second-Generation / therapeutic use*
  • Cyclohexanols / therapeutic use
  • Depressive Disorder / drug therapy*
  • Female
  • Humans
  • Korea
  • Male
  • Medication Adherence / statistics & numerical data*
  • Mianserin / analogs & derivatives
  • Mianserin / therapeutic use
  • Middle Aged
  • Mirtazapine
  • Outpatients
  • Paroxetine / therapeutic use
  • Retrospective Studies
  • Venlafaxine Hydrochloride

Substances

  • Antidepressive Agents, Second-Generation
  • Cyclohexanols
  • Mianserin
  • Paroxetine
  • Venlafaxine Hydrochloride
  • Mirtazapine